
HealthEquity (HQY) Stock Forecast & Price Target
HealthEquity (HQY) Analyst Ratings
Bulls say
HealthEquity is positioned to benefit from a durable expansion in its addressable market as high-deductible plans rise, HSA eligibility broadens, and the company continues to take share in a fragmented industry where it already has ~20%+ market share. The F2Q:27 print reinforced that thesis with revenue of $350.7M (+7.6% y/y), adjusted EBITDA of $167M (+11% y/y), a record ~48% EBITDA margin, and HSA members up 8% y/y, while new HSA sales rose 24% y/y and guidance for F2027E was raised. It also has multiple operating levers for further upside, including Enhanced Rates on ~$2.3B of HSA cash, only ~9% investing penetration, and technology/AI investments that are improving service efficiency, engagement, and margin expansion.
Bears say
HealthEquity is viewed negatively because its growth is exposed to a young, highly competitive HSA market with significant regulatory uncertainty, shifting healthcare rules, and rising adoption of alternative payment methods that could pressure utilization and balance growth. The company also faces material operational and financial risks from cyberattacks and fraud, including a class action lawsuit and millions in costs from a recent sophisticated attack, while ongoing investment in cybersecurity, R&D, and acquisitions may weigh on margins and execution. In addition, falling interest rates, a weakening labor market with unemployment above 5%, and recession-driven job losses could slow HSA contributions and reduce enhanced cash balance returns, reinforcing the downside case of 5% topline growth and 200 bps of margin contraction in 2027.
This aggregate rating is based on analysts' research of HealthEquity and is not a guaranteed prediction by Public.com or investment advice.
HealthEquity (HQY) Analyst Forecast & Price Prediction
Start investing in HealthEquity (HQY)
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About HealthEquity (HQY) Forecast
HealthEquity (HQY) Analyst Forecast & Price Prediction
Start investing in HealthEquity (HQY)
Order type
Buy in
Order amount
Est. shares
0 shares